Lipomics Technologies, Inc. to Launch Diagnostic Development Program in Liver Disease  
3/17/2008 11:56:12 AM

WEST SACRAMENTO, Calif., Mar. 17, 2008 - Lipomics Technologies, Inc., a privately held company that specializes in developing diagnostics for managing metabolic and cardiovascular disease, announced today that it is launching an effort to validate its proprietary biomarkers for fatty liver disease.